<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of this study was to evaluate whether a high <z:chebi fb="0" ids="17855">triglyceride</z:chebi>/<z:chebi fb="1" ids="47775">high-density lipoprotein cholesterol</z:chebi> (TG/<z:chebi fb="0" ids="47775">HDL-C</z:chebi>) ratio is associated with an increased incidence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Individuals with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (n = 979) with an estimated glomerular filtration rate greater than 60 mL/min and without <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> at baseline were followed up for the incidence of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (diagnosed by retinography) and CKD (diagnosed by estimated glomerular filtration rate â‰¤60 mL/min/1.73 m(2)) </plain></SENT>
<SENT sid="2" pm="."><plain>On follow-up (mean, 4.9 years), 217 (22.2% of total) subjects experienced CKD and/or diabetic-specific <z:hpo ids='HP_0007863'>retinal lesions</z:hpo> (microvascular complication) </plain></SENT>
<SENT sid="3" pm="."><plain>Of these, 111 subjects developed isolated <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, 85 developed CKD alone, and 21 developed both complications </plain></SENT>
<SENT sid="4" pm="."><plain>The TG/<z:chebi fb="0" ids="47775">HDL-C</z:chebi> ratio was positively associated with an increased risk of incident <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and/or CKD (composite microvascular end point) independently of age, sex, body mass index, <z:mp ids='MP_0002055'>diabetes</z:mp> duration, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> A(1c), <z:hpo ids='HP_0000822'>hypertension</z:hpo>, smoking history, <z:chebi fb="1" ids="47774">low-density lipoprotein cholesterol</z:chebi>, <z:mp ids='MP_0002871'>albuminuria</z:mp>, and current use of hypoglycemic, <z:chebi fb="0" ids="35674">antihypertensive</z:chebi>, <z:chebi fb="23" ids="18059">lipid</z:chebi>-lowering, or antiplatelet drugs (multivariable-adjusted odds ratio, 2.15; 95% confidence intervals, 1.10-4.25; P = .04) </plain></SENT>
<SENT sid="5" pm="."><plain>These findings suggested that the TG/<z:chebi fb="0" ids="47775">HDL-C</z:chebi> ratio was associated with an increased incidence of microvascular complications in individuals with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> without prior <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, independently of several potential confounders </plain></SENT>
</text></document>